Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 215-553-5 | CAS number: 1330-86-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- screening for reproductive / developmental toxicity
- Remarks:
- based on test type (migrated information)
- Type of information:
- migrated information: read-across based on grouping of substances (category approach)
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- GLP - Guideline study. According to the ECHA guidance document "Practical guide 6: How to report read-across and categories (March 2010)", the reliability was changed from RL1 to RL2 to reflect the fact that this study was conducted on a read-across substance.
Data source
Referenceopen allclose all
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 996
- Reference Type:
- secondary source
- Title:
- Dibutyl adipate CAS N°: 105-99-7
- Author:
- OECD
- Year:
- 1 996
- Bibliographic source:
- SIDS Initial Assessment Report for SIAM 4; Tokyo, Japan, 20-22 May 1996
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 421 (Reproduction / Developmental Toxicity Screening Test)
- Deviations:
- no
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- Dibutyl adipate
- EC Number:
- 203-350-4
- EC Name:
- Dibutyl adipate
- Cas Number:
- 105-99-7
- Molecular formula:
- C14H26O4
- IUPAC Name:
- dibutyl adipate
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories Japan, Inc., Yokohama, Japan
- Age at study initiation: 8 wks;
- Weight at study initiation: males: 270.6 - 326.5 g; females: 199.5 - 243.4 g
- Fasting period before study: No
- Diet: CA-1 by CLEA Japan, Meguro, Japan, ad libitum
- Water: tap water, ad libitum
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 24 ± 1
- Humidity (%): 55 ± 5
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on exposure:
- VEHICLE
- Justification for use and choice of vehicle: due to the lipophilic properties of the test material, corn oil was selected as the appropriate vehicle
- Amount of vehicle: 5 mL/kg - Details on mating procedure:
- - M/F ratio per cage: 1/1
- Length of cohabitation: up to 14 days
- Proof of pregnancy: vaginal plug and sperm in vaginal smear referred to as Day 0 of pregnancy
- After successful mating each pregnant female was caged: Individually - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Detailed method was not described. The measured concentration was between 98.3 and 104% of nominal concentration.
- Duration of treatment / exposure:
- Males: 14 days before mating and for 28 days thereafter
Females: total of 42-53 days beginning 14 days before mating to day 3 of lactation - Frequency of treatment:
- 7 days /week
- Details on study schedule:
- - Age at mating of the mated animals in the study: 10 weeks
Doses / concentrations
- Remarks:
- Doses / Concentrations:
100, 300, 1000 mg/kg bw/day
Basis:
actual ingested
- No. of animals per sex per dose:
- 13
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: A dose finding study was performed. Test solutions of 0, 500 and 1000 mg/kg bw/day were administered for 14 days to female rats. Slight salivation was observed during treatment but no mortality occured. No difference in body weight and food consumption was observed and necropsy revealed no abnormalities.No change in organ weight compared with control group was observed.
Examinations
- Parental animals: Observations and examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: twice daily, before and after administration
BODY WEIGHT: Yes
- Time schedule for examinations: Males on Days 1, 8, 15, 22, 29, 36 and 43, females on Days 1, 8 and 15 of treatment, Days 0, 7, 14 and 20 of gestation and Days 0 and 4 of lactation
FOOD CONSUMPTION: not examined - Oestrous cyclicity (parental animals):
- Observed
- Sperm parameters (parental animals):
- Parameters examined in parental animals:
testis weight, epididymis weight, other: histopathology - Litter observations:
- PARAMETERS EXAMINED
The following parameters were examined in F1 offspring:
number and sex of pups, stillbirths, live births, postnatal mortality, presence of gross anomalies, weight gain, physical or behavioural abnormalities
GROSS EXAMINATION OF DEAD PUPS:
yes, for external and internal abnormalities - Postmortem examinations (parental animals):
- SACRIFICE
- Male animals: All surviving animals on Day 43
- Maternal animals: All surviving animals on Day 4 of lacation
GROSS NECROPSY
- Gross necropsy consisted of external and internal examinations including the cervical, thoracic, and abdominal viscera.
HISTOPATHOLOGY / ORGAN WEIGHTS
Organ weight: kidneys and spleen of both sexes and testes and epididymides of males.
Microscopic observation: testes and epididymides of males; ovary and uterus of females - Postmortem examinations (offspring):
- SACRIFICE
- The F1 offspring were sacrificed at 4 days of age.
GROSS NECROPSY
- Gross necropsy consisted of external and internal examinations. - Statistics:
- Barlett's test, Dunett's test, Scheffe's test, Kruskal-Wallis test
- Reproductive indices:
- copulation index (no. of copulated rats/no. of mated rats x 100),
fertility index (no. of pregnant females/no. of females with successful copulation x 100),
gestation index (no. of females with live pups/no. of pregnant females x 100),
implantation index (no. of implantation sites/no. of corpora lutea x 100),
delivery index (no. of pups born/no. of implantation sited x 100) - Offspring viability indices:
- birth index (no. of live pups on day 0/no. of implantation sites x 100),
live birth index (no. of live pups on Day 0/no. of pups born x 100),
viability index (no. of pups alive on Day 4 of lactation/no. of pups born x 100)
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- Dose-dependent increase in number of rats with salivation after dose administration in both sexes.
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Histopathological findings: non-neoplastic:
- no effects observed
- Other effects:
- no effects observed
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- no effects observed
- Reproductive function: sperm measures:
- no effects observed
- Reproductive performance:
- no effects observed
Details on results (P0)
Slight salivation was observed in treatment group with dose-responsibility (see Table 1). This change was not regarded as neurological effect but caused by stimulation by the administration of the test compound.
BODY WEIGHT AND FOOD CONSUMPTION (PARENTAL ANIMALS)
Light suppression of body weight gain was observed in males in 1000 mg/kg group but there was no significant difference.
ORGAN WEIGHTS (PARENTAL ANIMALS)
An increase in relative weight of kidney was observed in both sexes of 1000 mg/kg bw group. An increase in relative weight of spleen in males of 100 and 1000 mg/kg bw, increase in absolute weight of spleen in females of 100 mg/kg was observed ( see Table 2).
HISTOPATHOLOGY (PARENTAL ANIMALS)
Infiltration of lymphocyte in testis was observed in control and 1000 mg/kg group. This change was not related to the test compound.
OTHER FINDINGS (PARENTAL ANIMALS)
A dam in 300 mg/kg bw group didn't retrieve pups and all pups were dead until on PND 2. But this change was not regarded as compound-related effect.
Effect levels (P0)
open allclose all
- Dose descriptor:
- NOAEL
- Remarks:
- systemic
- Effect level:
- 300 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: organ weights: kidney weights increased
- Dose descriptor:
- NOAEL
- Remarks:
- reproduction
- Effect level:
- >= 1 000 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: NOAEL for reproductive parameters is corresponding to the highest dose tested
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- no effects observed
- Mortality / viability:
- mortality observed, treatment-related
- Description (incidence and severity):
- 1000 mg/kg: Pup viability on PND 4 was decreased.
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- 1000 mg/kg bw: pup weight on PND 0 and 4 was slightly decreased (without reaching statistical significance)
- Sexual maturation:
- not examined
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- no effects observed
- Histopathological findings:
- no effects observed
Details on results (F1)
1000 mg/kg: Pup viability on PND 4 was statistically significantly decreased (see Table 3).
CLINICAL SIGNS (OFFSPRING)
No effects were observed.
BODY WEIGHT (OFFSPRING)
1000 mg/kg bw: pup weight on PND 0 and 4 was slightly decreased (without reaching statistical significance (see Table 3).
GROSS PATHOLOGY (OFFSPRING)
No effects were observed.
Effect levels (F1)
- Dose descriptor:
- NOAEL
- Generation:
- F1
- Effect level:
- 300 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: pup weight; viability index
Overall reproductive toxicity
- Reproductive effects observed:
- not specified
Any other information on results incl. tables
Table 1: Number of animals showing salivation upon treatment [male/female]
|
Dose [mg/kg bw/day] |
|||
Days of treatment |
0 |
100 |
300 |
1000 |
1-7 |
- |
- |
- |
12/9 |
18-14 |
- |
-/1 |
4/4 |
13/13 |
15-21 |
- |
3/2 |
7/9 |
13/13 |
22-28 |
- |
- |
2/1 |
12/13 |
29-35 |
- |
- |
6/4 |
13/13 |
36-42 |
- |
- |
6/3 |
13/12 |
43 |
- |
- |
- |
- |
Total |
- |
3/3 |
11/9 |
13/13 |
Table 2: Organ weights
Males after 42 days of treatment |
Dose [mg/kg bw/day] |
||||
Kidney |
|
0 |
100 |
300 |
1000 |
absolute weight [g] |
mean |
2.96 |
3.12 |
3.04 |
3.08 |
|
SD |
0.39 |
0.34 |
0.32 |
0.35 |
relative weight [% of mean body weight] |
mean |
0.6 |
0.61 |
0.63 |
0.65* |
|
SD |
0.05 |
0.04 |
0.06 |
0.06 |
Spleen |
|||||
absolute weight [g] |
mean |
0.79 |
0.95 |
0.84 |
0.9 |
|
SD |
0.14 |
0.19 |
0.11 |
0.2 |
relative weight [% of mean body weight] |
mean |
0.16 |
0.18* |
0.17 |
0.19** |
|
SD |
0.02 |
0.03 |
0.02 |
0.03 |
Females at Day 4 of lactation |
|||||
Kidney |
|||||
absolute weight [g] |
mean |
1.95 |
1.97 |
2.1 |
2.11 |
|
SD |
0.15 |
0.19 |
0.22 |
0.17 |
relative weight [% of mean body weight] |
mean |
0.6 |
0.58 |
0.62 |
0.65 |
|
SD |
0.04 |
0.03 |
0.05 |
0.07 |
Spleen |
|||||
absolute weight (in g) |
mean |
0.59 |
0.74* |
0.65 |
0.68 |
|
SD |
0.08 |
0.16 |
0.13 |
0.09 |
relative weight (% of mean body weight) |
mean |
0.18 |
0.22 |
0.19 |
0.21 |
|
SD |
0.03 |
0.04 |
0.03 |
0.03 |
Table 3: Reproductive parameters
Dose [mg/kg bw/day] |
|
0 |
100 |
300 |
1000 |
No.of female animals: |
|
13 |
13 |
13 |
13 |
No. of mated pairs: |
|
13 |
13 |
13 |
13 |
No. of copulated pairs: |
|
13 |
13 |
13 |
13 |
Copulation index [%] |
|
100 |
100 |
100 |
100 |
No. of pregnant females |
|
12 |
12 |
12 |
12 |
Fertility index [%] |
|
92.3 |
92.3 |
92.3 |
92.3 |
Pairing day until copulation |
|
||||
|
mean |
4.1 |
2.6 |
3 |
2.7 |
|
SD |
3.3 |
0.8 |
2.3 |
1 |
Frequency of vaginal estrus |
|
||||
|
mean |
1.1 |
1 |
1.2 |
1 |
|
SD |
0.3 |
0 |
0.6 |
0 |
No. of pregnant females with pups alive: |
|
12 |
12 |
12 |
12 |
Gestation index (%) |
|
100 |
100 |
100 |
100 |
Gestation length (days) |
|
||||
|
mean |
22.3 |
22.1 |
22.2 |
22.2 |
|
SD |
0.5 |
0.3 |
0.4 |
0.4 |
No. of corpora lutea |
|
||||
|
mean |
15.7 |
15.6 |
17 |
16.9 |
|
SD |
2 |
1.6 |
1.9 |
1.7 |
No.of implantation site |
|
||||
|
mean |
14.8 |
14.7 |
15.8 |
15.5 |
|
SD |
2.6 |
2.1 |
3.1 |
2.1 |
Implantation index [%] |
|
||||
|
mean |
94.2 |
94 |
92.2 |
91.5 |
|
SD |
7.8 |
8.4 |
14.1 |
7.5 |
Day 0 of lactation |
|
||||
No.of pups born |
|
||||
|
mean |
13.6 |
14.2 |
15 |
14.6 |
|
SD |
2.4 |
1.9 |
2.9 |
2.3 |
Delivery index [%] |
|
||||
|
mean |
91.8 |
96.7 |
95.5 |
93.9 |
|
SD |
6.5 |
3.4 |
5.7 |
5.9 |
No.of pups alive |
|
||||
|
mean |
13.3 |
13.9 |
14.3 |
13.7 |
|
SD |
2.4 |
1.9 |
2.6 |
3.3 |
Birth index (%) |
|
||||
|
mean |
90.1 |
95.2 |
91.8 |
88.2 |
|
SD |
6.1 |
6 |
8.8 |
16.8 |
Live birth index (%) |
|
|
|
|
|
|
mean |
98.2 |
98.4 |
96.2 |
93.6 |
|
SD |
4.6 |
4.1 |
8.4 |
15.2 |
Pups weight [g] |
|
||||
Male |
mean |
6.5 |
6.4 |
6.2 |
6.1 |
|
SD |
0.7 |
0.6 |
0.8 |
0.7 |
Female |
mean |
6.1 |
6 |
5.8 |
5.8 |
|
SD |
0.6 |
0.6 |
0.7 |
0.5 |
Sex ratio on day 0 of lactation [no. of male pups/total no. of pups] |
|
||||
|
mean |
47.6 |
41.4 |
49.4 |
48.6 |
|
SD |
13 |
7.7 |
12.7 |
11.9 |
Day 4 of lactation |
|
||||
No.of pups alive |
|
||||
|
mean |
13.3 |
13.8 |
13.1 |
13.3 |
|
SD |
2.4 |
1.7 |
4.8 |
3.5 |
Viability index [%] |
|
||||
|
mean |
100 |
99.5 |
90.6 |
96.1* |
|
SD |
0 |
1.7 |
28.6 |
5.3 |
Pups weight [g] on day 4 of lactation |
|
||||
Male |
mean |
10.6 |
10.8 |
10.2 |
9.9 |
|
SD |
1.8 |
1.2 |
1.7 |
1.9 |
Female |
mean |
10.1 |
10.1 |
9.7 |
9.3 |
|
SD |
1.7 |
1.2 |
1.6 |
1.4 |
SD standard deviation
* significant difference from control, p<0.05
** significant difference from control, p<0.01
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.